goto Indian Health Service home page  Indian Health Service:  The Federal Health Program for American Indians and Alaska Natives

 
IHS HOME ABOUT IHS SITE MAP HELP
goto Health and Human Services home page goto Health and Human Services home page

Syphillis in Pregnancy

Contact Us

MCH Website Administrator

Required Plugins

These plug-ins
may be required
for the content
on this page:


Link to Adobe Acrobat Plug-in Acrobat
Link to MicroSoft Word Plug-in MS Word

IHS Plug-in Page

Use site contact
if unable to view
a particular file

Maternal Child

Maternal Child HealthPerinatologist Corner ‹ C.E.U./C.M.E. Modules

Perinatologist Corner - C.E.U/C.M.E. Modules

Syphilis in Pregnancy

Sponsored by The Indian Health Service Clinical Support Center

9. Congenital Syphilis

 

 

Case Scenario 4

 

D. S. is a 30 y/o G2P1, who had a negative RPR on her NOB labs at 15 weeks, has just delivered. The lab reports a positive RPR on her newborn's cord blood. The infant is well and has a normal physical exam. How should you manage this situation?

 

Congenital Syphilis

 

As stressed above, maternal serologic testing, and appropriate maternal treatment, remain the best preventive strategy for congenital syphilis. ExitDisclaimer Nevertheless, all infants born to women with positive serology, treated or untreated, should be examined for evidence of infection. Jaundice, hepatosplenomegaly, rhinitis, rash, pseudoparalysis of an extremity, or radiologic evidence of periostitis or pneumonitis, strongly suggest neonatal disease. Such infants should have serologic studies performed on themselves and their mothers, and be treated as detailed below.

 

Serologic testing of maternal blood at the time of delivery is superior to infant testing because low maternal titers or late pregnancy maternal infections may result in false negative results in the infant. Conversely, transfer of maternal antibodies, even in adequately treated mothers, may result in false positives without actual vertical transmission. Umbilical cord blood testing is not recommended because of possible contamination with maternal blood, and because Wharton's jelly itself has been reported to be a cause of a false positive reaction with non-treponemal antibody testing. Treatment decisions need to be made on the basis of maternal history and treatment. Was the mother treated? Was she treated adequately? Was she treated with a non-penicillin regimen? Was she treated <4 weeks before delivery? Has she had a fourfold decrease in titer after treatment? Does the infant have clinical signs (see above)? A comparison of maternal and infant non-treponemal test titers is very helpful for guiding therapy. No currently available IgM treponemal test is considered reliable, so a VDRL or RPR on infant serum is the appropriate test to order.

 

 

 

 

 

8. Penicillin-allergic patients‹ Previous | Next › 10. Infant clinical examples

up arrow Return to top of page

This file last modified: Tuesday November 6, 2007  1:31 PM